ABSTRACT
INTRODUCTION
Glycemic control is an important part of diabetes self-management for patients with type 1 and type 2 diabetes [1] . Research suggests that adequate and timely glycemic control, as measured by hemoglobin A1c (HbA1c) values, reduces the risks of microvascular and macrovascular complications related to diabetes [1] [2] [3] [4] . While research on diabetes management has focused primarily on the role of HbA1c and fasting plasma glucose (FPG) for the measurement of glycemic control, recent data suggest that blood glucose (BG) after eating or post-prandial blood glucose (PPG), also plays an important role in glycemic control and glycemic variability on a day-to-day basis, and provide additional information not captured by HbA1c values [5] . In particular, elevated PPG or post-prandial hyperglycemia (PPH) may be an important consideration for improving glycemic control and diabetes self-management, and ultimately reduce the risk of diabetes-related complications. According to the ADA, the PPG target 1-2 h post-meal is \180 mg/dL, while the IDF recommends a PPG target of \160 mg/dL; the AACE's recommended PPG target 2 h post-meal is \140 mg/dL [1, 2, 6] . A recent clinical study based on the IDF threshold found that among patients with type 2 diabetes not treated with insulin therapy, 84% had experienced PPH at least once in the previous week [7] . Post-prandial blood glucose (PPG) is an important part of overall glycemic control, and research has shown that PPH is associated with a significantly increased risk of cardiovascular disease (CVD) and cardiovascular events among individuals with and those without diabetes [8] [9] [10] . Some research suggests that PPG may be a better predictor of cardiovascular events than FPG [11, 12] . In addition to CVD and cardiovascular events, several long-term studies of individuals with and without diabetes have shown that PPH or elevated post-challenge glucose following an oral glucose tolerance test is significantly associated with increased risks of both all-cause mortality and CVD mortality [11, [13] [14] [15] [16] , as well as pancreatic cancer mortality [17] . PPH has also been associated with a number of other negative health outcomes, including decreased cognitive functioning among elderly patients with type 2 diabetes [18] , oxidative stress, endothelial dysfunction, retinopathy, and some cancers [2] . Research has also suggested that PPH may contribute to greater use of healthcare resources and related costs among diabetic patients [19] . 
Survey Development
To develop the survey, semi-structured focus groups were conducted with 77 participants recruited by focus group facilities who were diagnosed with diabetes and using bolus insulin in Germany (n = 20), the UK (n = 17), and the USA (n = 40). Survey items were generated through the analysis of focus group transcripts, based on adapted grounded theory [21] . Once generated, survey items underwent cognitive debriefing with 12 individuals diagnosed with diabetes (recruited by focus group facilities, but not participants in the study focus groups) to reach consensus that instructions and items were clear, understandable, relevant and inoffensive, to ensure the recall period was appropriate, and to confirm that the format and structure of the survey were acceptable. The final survey comprised 85 questions and took approximately 30 min to complete.
Participants
The web-based survey was administered to participants recruited from research panels maintained by professional market research firms in the three countries via a secure internet server, which participants accessed via their computers. Potential respondents were selected from pre-existing panels of individuals who had previously agreed to be approached to participate in surveys. These pre-existing panels were used for research purposes only.
Respondents were required to complete a brief online screening survey to ensure eligibility for participation. Respondents whose most recent experience of out-of-range PPG was PPH (as opposed to post-prandial hypoglycemia or being unsure) were asked additional questions about their experiences of PPH, including how they knew they were experiencing PPH, reasons for PPH, situations and factors contributing to PPH, and corrective actions taken following PPH.
Respondents were questioned on the 
RESULTS

Sample Description
A total of 906 respondents in three countries completed the survey [Germany, n = 305 (type 1, n = 130; type 2, n = 175); UK, n = 236 (type 1, n = 117; type 2, n = 119), US, n = 365 (type 1, 
Out-of-range Post-Prandial Glucose in the Previous Week
Two-thirds of respondents (66.3%) indicated experiencing some level of difficulty with out-of-range PPG in the past week, with 7.0% reporting that it was ''very'' or ''extremely'' difficult, and 59.3% reporting that it was ''a little'' or ''somewhat'' difficult to get their BG stable after eating. Difficulty with out-of-range PPG in the past week did not differ significantly by diabetes type. Chi-square/t tests indicate significant differences by diabetes type, * p\0.05; *** p\0.001 a Restricted to employed respondents, n = 519
As shown in Fig. 1, 61 .9% of respondents indicated that they experienced PPH in the past week, 30.0% experiencing three or more episodes in the past week. A total of 35.8% of respondents experienced post-prandial hypoglycemia in the past week, with 11.3% experiencing three or more episodes in the past week. Respondents reported an average of 1.7 episodes of PPH over the course of the week and an average of 0.6 episodes of post-prandial hypoglycemia during the last week.
Respondent Experiences and Management of PPH
Respondents were asked to report on their most recent episode of out-of-range PPG ( 36.8%; p\0.01) than those who did not experience PPH. Reported physical activity did not differ significantly between those who had and had not experienced PPH in the past week.
Significant differences in emotions when
taking bolus insulin were evident, with those who experienced PPH in the past week significantly more likely to report feeling very/ extremely ''grateful'' (31.6% vs. 23.2%; p\0.01), ''worried'' (10.2% vs. 5.2%; p\0.01), ''guilty'' (9.8% vs. 4.3%; p\0.01), ''discouraged'' (11.8% vs. 5.2%; p\0.01), ''frustrated'' (12.5% vs. 6.4%; p\0.01), ''embarrassed'' (8.2% vs. 4.1%; p\0.05), and ''angry'' (9.3% vs. 4.6%, p\0.05) when taking bolus insulin compared with those who did not experience PPH (Table 3) . Additionally, those who experienced PPH in the past week were significantly less likely to report that they were very/extremely confident in calculating their bolus doses accurately (52.9% vs. 67.5%; p\0.001) compared with those who did not experience PPH. Regarding diabetes-related concerns, those who experienced PPH were significantly more likely to indicate being very/extremely worried about future diabetes complications (45.6% vs. 25.8%; p\0.001), whether insulin was controlling their diabetes (30.1% vs. 13.0%; p\0.001), high blood sugar events (30.7% vs.
9.6%; p\0.001), low blood sugar events (24.8% vs. 11.3%; p\0.001), whether they were calculating bolus insulin doses correctly (21.6% vs. 10.7%; p\0.001), and using their insulin devices (9.8% vs. 4.1%; p\0.01).
Associations between PPH and respondent emotions when taking bolus insulin differed somewhat by diabetes type. The positive relationships between PPH and some emotions when taking bolus doses were significant among respondents with type 1 diabetes, but not among those with type 2 diabetes, including feeling very/extremely ''grateful'' (p\0.05) and ''embarrassed'' (p\0.05). In addition, the associations between experience of PPH and a number of emotions when taking bolus insulin Table 3 Respondents' feelings about bolus insulin and general worries related to diabetes according to whether they had experienced post-prandial hyperglycemia in the past week (7 days) 
DISCUSSION
Addressing PPH may be critical for achieving better BG control, thereby reducing the risks of diabetes-related complications and mortality [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . Consistent with prior research [2, 7] 
